Verseon
Fremont
About Verseon
Verseon is a technology-based pharmaceutical company developing novel therapeutics for today’s challenging diseases. The company’s proprietary drug discovery platform is the first systematic, computationally-driven solution to achieve the molecular modeling accuracy necessary for rapid and cost-effective drug discovery. Verseon plans to use its platform to establish a diversified discovery pipeline across multiple disease areas. It was founded in 2002 and is headquartered in Fremont, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $124.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2019)
- Ticker: lse:VSN
- Website: verseon.com
- Phone: +1 510 225 9000
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/verseon-33612 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.